Cell behaviour is strongly influenced by physical, mechanical contacts between cells and their extracellular matrix. We review how the transcriptional regulators YAP and TAZ integrate mechanical cues with the response to soluble signals and metabolic pathways to control multiple aspects of cell behaviour, including proliferation, cell plasticity and stemness essential for tissue regeneration. Corruption of cell-environment interplay leads to aberrant YAP and TAZ activation that is instrumental for multiple diseases, including cancer.
F undamental aspects of cell behaviour in living organismsmorphogenesis, collective migration and self-organizationare not genetically encoded but are emergent properties of cells interconnected within a tissue network. Furthermore, most disease states either do not have a genetic origin, or, as is the case in cancer, are preceded or accompanied by a corruption of the tissue environment that fuels aberrant cell behaviour 1, 2 . Our current knowledge of signalling pathways regulating gene expression, proliferation and fate decisions does not fully account for these emergent properties, failing to explain how these events are exquisitely localized in living tissues. Understanding the spatiotemporal control of cell behaviour thus requires incorporation of information on how structural and architectural complexity of tissues is transmitted to their constituent cells.
YAP and TAZ, two highly related transcriptional regulators (hereafter referred to as YAP/TAZ), sense how cells perceive themselves and their tissue environment and communicate with it. YAP/ TAZ activity in a cell is under direct control of its shape and polarity, which is in turn dictated by the cytoskeletal structure 3 . Further, the tensional state and organization of the cytoskeleton reflect the local pattern of geometrical and mechanical strains associated with the position of the cell within the global three-dimensional (3D) tissue architecture and surrounding stromal composition 4, 5 . These inputs are essentially physical, and include the pattern of forces emanating from the cell's attachment to other cells as well as the topology and rigidity of the extracellular matrix (ECM) 6 . YAP/TAZ convert such inputs into gene expression signatures and coherent, contextdependent biological responses 3, 7 .
The structural features of a cell must also be linked to its metabolism and its responsiveness to other environmental cues, such as morphogen signals and nutrient availability. For example, epithelial budding starts with localized distortion in the shape of a few cells preceding their proliferation, suggesting that localized changes in mechanics can determine the response to mitogens 8 . Notably, cells respond to mechanical stresses by adjusting composition and fine 3D organization of the surrounding ECM, and by reorganizing cell-cell adhesion. Thus, inward directed forces (generated by cytoskeletal contractility), deformation of organelles and external forces (pulling from ECM rigidity, other cells or fluid flow) are always in perfect balance 5, 6 . Here, we review recent data providing an emerging picture in which YAP/TAZ serve as a nexus orchestrating the interplay between cellular mechanics, metabolism and developmental signalling cascades, allowing for cell and context-specific responses. We also discuss the possibility that the YAP/TAZ transcriptional program may be devoted to the instalment of positive feedback systems promoting YAP/TAZ-mediated mechanical and metabolic signalling. Through such mechanisms YAP/TAZ shape organs during development, forge self-organization phenomena and adapt cell behaviour to tissue needs, as in tissue repair or regeneration. When elements of this control fail or are imbalanced, abnormal YAP/TAZ activation causes multiple diseases, including fibrosis, cancer and atherosclerosis 3 . Finally, we outline some exciting open issues in the burgeoning field of YAP/TAZ regulation and biology.
YAP/TAZ sense and respond to biomechanical signals
In order to harmonize their behaviour to the surrounding mechanical niches, cells must translate external cues into signalling conduits that impact gene expression, a process referred to as mechanotransduction 4 . Mechanotransduction starts with the ability of cells to probe the physical features of the microenvironment through integrins and other adhesive proteins, and to counterbalance extracellular forces by adjusting their own tensional state through actomyosin contractility and organization of the F-actin cytoskeleton 4 . For years, these models left unaddressed the question of how mechanical instructions are executed in the nucleus through specific transcription factors (TFs). Strikingly, recent discoveries are converging on a model in which multiple types of mechanical inputs in a variety of cellular settings rely on the regulation of two transcriptional regulators, YAP and TAZ (reviewed in 3, 9 ). Note that here we depict YAP and TAZ as equivalent proteins, this is based on their structural similarities and genetic redundancy in a host of experimental conditions and biological functions. However, these proteins display different phenotypes in individual mouse knockout lines 10, 11 , and dissecting individual functions from overlapping ones is an open issue for the field.
YAP/TAZ activity is regulated by the conformation and tension of the F-actin cytoskeleton, which in turn depend primarily on the substrate to which cells adhere. Indeed, cells spread when plated on large and stiff substrates; in these conditions, they display high ROCK-and non-muscle-myosin-II-driven cytoskeletal tension ultimately turning on YAP/TAZ. Conversely softer or smaller substrates, imposing cell rounding and reduced adhesive area,
YAP/TAZ upstream signals and downstream responses
cause cytoplasmic retention and inhibition of YAP/TAZ (refs 12,13 ) (Fig. 1) . Importantly, this is an evolutionarily conserved mechanism, shared by multiple cell types, attesting the generality of YAP/ TAZ mechanotransduction 3, 7 . Indeed, a potent means to induce YAP/TAZ activity is raising F-actin reorganization and stress fibre formation by experimental depletion of capping and severing proteins, such as Cofilin-1 and CapZ (ref. 13 ). Different sub-pools of F-actin can, however, have opposite roles on YAP/TAZ activity as in highly polarized cell cultures, where contraction of the apical circumferential actin belt is required to inhibit YAP/TAZ (ref.
14 ). This phenomenon possibly involves the formation of an apical F-actin network by the spectrin family of scaffolding proteins. Indeed, depletion of spectrins results in aberrant YAP/TAZ nuclear localization in Drosophila wing, ovary follicle cells and Madin-Darby canine kidney (MDCK) cells, possibly due to abnormal restructuring of F-actin into basal stress fibres 15, 16 . The finding that molecular components of focal adhesions (FAs), namely integrins, focal adhesion kinase (FAK) and Src, are required for YAP/TAZ activity is consistent with the fact that the degree of cell distortion and spreading are key signals impinging on the arrangement of the F-actin cytoskeleton and YAP/TAZ activity ( Fig. 1) . The relationship between cell shape, F-actin and YAP/TAZ activity impacts hepatic stellate cell conversion to myofibroblasts during liver fibrosis [17] [18] [19] , proliferation of basal layer skin keratinocytes 20, 21 , activation and proliferation of cancer associated fibroblasts 22 , self-renewal and chemoresistance of breast cancer stem cells (CSCs) induced by glucocorticoids 23 , the atherogenic effect of disturbed blood flow on endothelial cells 24, 25 and post-damage intestinal regeneration 26 . Mechanistically, YAP/TAZ activation by integrin-dependent FA formation may be linked to the activation of the Rho guanidine exchange factor β -PIX, the small GTPase Rac1 and its effector p-21 activated kinase (PAK) (refs 27,28 ), which are known F-actin modulators, suggesting a role for integrin-dependent cytoskeletal modifications in mechanical regulation of YAP/TAZ (Fig. 1) . Moreover, Yes/Src family proteins directly phosphorylate YAP to promote YAP transcriptional activity 21, 29 . Still unclear, however, is to what extent Src impacts on YAP/TAZ function directly, through phosphorylation, rather than indirectly, through its effects on the cytoskeleton. Intriguingly, the dynamic formation of FAs is itself influenced by substrate stiffness. Indeed, a molecular clutch model for FAs implies that sufficient substrate stiffness is required for integrin-bound talins to unfold and expose a vinculin-binding domain to promote full FA maturation and YAP/TAZ nuclear accumulation 30 . This suggests that FA components might not only be required for adhesion to the substrate but can act as mechanotransducing units 31 ( Fig. 1) . Notably, the main YAP-regulating mechanosensitive adhesive platforms are those exerting the highest force, that is the β 1-integrin clusters more proximal to the nucleus connecting F-actin filaments to the nuclear lamina, but not the peripheral FAs, which appear inconsequential for YAP/TAZ regulation 32 . Altogether, it appears that YAP/TAZ regulation is not guided by the total levels of F-actin but its subcellular organization, fine structure, tension and, likely, resistance offered by molecular struts within the cytoskeleton (such as microtubules 33 and, potentially, intermediate filaments), and by the whole nucleus. Therefore, YAP/TAZ mechanotransduction differs profoundly from actin regulation of myocardin-related transcription factor (MRTF) family, a sensor of F-actin/G-actin ratio that binds directly to free, nuclear G-actin in a manner that inhibits its association with its DNA-binding partner serum response factor (SRF) 34 . Integrin signalling is critical for modulation of YAP/TAZ activity in 3D, and relevant to instruct differentiation of cultured skeletal stem cells and to drive proliferation of malignant cells 13, 35 . Yet, regulation of YAP/TAZ in normal, primary epithelial cells, growing within physiological matrices as organoids, requires an additional level of complexity. When intestinal organoids are cultured in nondeformable 3D hydrogels of defined stiffness and composition, YAP/TAZ are induced at high stiffness, triggering proliferation of stem cells, but only transiently 26, 36 . As the organoid expands, YAP/ TAZ are turned off, possibly as an effect of increased cell crowding, causing loss of stemness and organoid demise. In contrast, when the hydrogel is designed to be physically plastic-allowing its proteolytic degradation by metalloproteases-fate plasticity and self-organization emerge. Under these conditions, YAP/TAZ activity remains localized at the tip of the organoid's crypt-like budding protrusions, a location characterized by elevated cellular strain where YAP/TAZ preserve the intestinal stem cells of the organoid 36 . Similarly, skeletal stem cells require the activity of matrix metalloproteinase MMP14 to remodel the surrounding collagen matrix in order to form integrin clustering, raising F-actin cytoskeletal tension that ultimately results in YAP/TAZ activation 35 . What determines the spatial specificity of crypt formation in developing organoids remains mysterious. Is it stochastic variegation in the Matrigel hydrogel? Or is it intrinsic to cell heterogeneity within the organoids, for example arising from differential MMP expression?
It must be noted, however, that cell spreading can lead to YAP/ TAZ activation independently of the formation of FAs (ref. ).
Signalling by diverse ECM components can trigger YAP/TAZ activity in different tissue types. For example, in the neonatal mouse heart, the ECM proteoglycan Agrin binds the dystrophin-glycoprotein complex (DGC) and induces YAP nuclear accumulation, promoting cardiomyocyte proliferation [37] [38] [39] ( Fig. 1) . Mechanical signalling by Agrin also regulates hepatocellular carcinoma (HCC) cells, in which Agrin is bound by the receptors LRP4-MUSK to enhance integrin-β 1-FAK1 signalling and YAP/TAZ mechanotransduction 40 . Other membrane-bound proteins, which are not necessarily adhesion molecules, can transduce mechanical signals to YAP/TAZ, as the Ca 2+ ion channel Piezo1 in human neural stem cells (NSCs), which is activated when NSCs are experiencing a stiff substrate, resulting in YAP/TAZ activation 41 . A major open question in the field is how, mechanistically, signalling information generated by the F-actin cytoskeleton turns YAP/TAZ subcellular localization and activity on or off. One possibility is that angiomotin family proteins (AMOTs) act as mechanical mediators between F-actin structures and YAP/TAZ. AMOTs directly bind and potentially inhibit YAP/TAZ (ref. 42 ). Moreover, AMOTs interact with F-actin in a manner mutually exclusive with their YAP/TAZ association 43 . However, validation of AMOTs as mechanotransducers and bona fide YAP/TAZ inhibitors is lacking 44 . The nucleus itself can act as a mechanosensitive subcellular compartment by means of the interaction between F-actin and the LINC protein complex, as extensively reviewed elsewhere 45 . Recent work has proposed that YAP/TAZ entry in the nucleus occurs by increasing permeability of nuclear pores through LINC-regulated nuclear stretching ( Fig. 1) 
46
. At the same time, disruption of F-actin anchoring to LINC causes a global collapse of the stress fibres spanning the nucleus, with ensuing YAP/TAZ inhibition 32 .
Cell polarity regulates YAP/TAZ through Hippo signalling
The Hippo pathway is an evolutionary conserved kinase cascade initially uncovered by genetic screens for tissue overgrowth mutants in Drosophila melanogaster [47] [48] [49] [50] [51] . The core of the mammalian Hippo pathway is composed of a two-kinase module in which the mammalian STE20-like kinase 1 (MST1) and MST2 (orthologues of Hippo in Drosophila), in cooperation with their binding partner SAV1, phosphorylate and activate large tumour suppressor 1 (LATS1) and LATS2 (orthologues of Warts in Drosophila). In turn, activated LATS proteins, aided by the co-factor MOB-1, directly phosphorylate YAP/TAZ and inhibit their activity through cytoplasmic retention and protein degradation 52 ( Fig. 2a) . Alternatively to the MST1/2 pathway, members of the MAPK4K family of mitogen-activated protein kinases phosphorylate and activate LATS, resulting in YAP/TAZ inhibition 53, 54 . A potent upstream inducer of the Hippo pathway is Merlin, which serves as scaffold for the core Hippo kinase module at cell-cell junctions in epithelial cells 55, 56 . Indeed, epithelial architecture, with the engagement of cell-cell junctions and apicobasal polarity, is a strong inhibitor of YAP/TAZ activity. Low ECM resistance corresponds to reduced adhesion and focal adhesion maturation, low actomyosin contractility and YAP/TAZ inactivation by, as yet, unclear cytoplasmic or nuclear inhibitors (brown ring). b, High ECM resistance favours integrin clustering and intracellular tension, disabling YAP/TAZ mechanically-regulated inhibitory mechanisms (red cross), allowing for YAP/TAZ function. c, The F-actin cytoskeleton integrates mechanical strain arising from cell-ECM and cell-cell adhesions. These physical inputs are transduced into YAP/TAZ function. YAP/TAZ activation is mediated by release of YAP/TAZ from inhibitors but also entails modulation of YAP/TAZ nuclear-cytoplasmic shuttling. The F-actin cytoskeleton impacts on the mechanics and shape of the nucleus through nesprin and SUN complexes, favouring YAP/TAZ nuclear entry by inducing nuclear deformation and increased permeability of the NPC. Left inset shows schematic representation of the signalling cascade that triggers actomyosin deposition and contractility at integrin-mediated focal adhesions. Right inset shows ECM components laminin and agrin signalling to the actomyosin cytoskeleton through the dystroglycan-dystrophin complex. β PIX, PAK-interacting exchange factor beta; NPC, nuclear pore complex; RhoGEFs, Rho guanidine nucleotide exchange factors; ROCK, Rho-associated protein kinase; SUN, SUN domain-containing protein.
Mechanistically, cell polarity is associated with the membrane localization of Scribble, which serves as scaffold for a MST-LATS-TAZ complex that favours YAP/TAZ inhibition 57 . Other polarity proteins also impact on YAP/TAZ function, such as the apical crumbs complex (CRB) that binds to YAP/TAZ and favours their cytoplasmic localization 58 ( Fig. 2a) . Loss of cell polarity is a general The destruction complex is a multiprotein machine at the core of the canonical Wnt pathway, controlling the intracellular levels of β -catenin. In the 'Wnt OFF' state (left), YAP/TAZ associate with axin, to be incorporated in the destruction complex together with β -catenin. As such, the complex restrains both β -catenin and YAP/TAZ activity regulating their sequestration and/or degradation in the cytoplasm. In the presence of a 'Wnt ON' state (right), the destruction complex is inhibited as axin and GSK3 bind to Wnt receptors, LRP5/6, that being internalized into multi-vesicular bodies. Disassembly of the complex by Wnt ligands abolishes both β -catenin and YAP/TAZ cytosolic inhibition, triggering their nuclear accumulation and consequent activation of transcriptional responses 81 . The role of the destruction complex as checkpoint coordinating YAP/TAZ activity has been further corroborated by recent reports, including the findings that: SCD1 activity promotes the secretion of active (that is, lipid-modified) Wnt ligands, leading to YAP/TAZ activation 86 (right); cytosolic TIAM1 is incorporated in the destruction complex to promote β -TrCP-dependent YAP/TAZ degradation and sequestration 87 (left); actin regulator WIP stabilizes YAP/TAZ proteins by inhibiting internalization of the destruction complex in MVBs 85 (right); and tumour suppressor PKCζ associates with the destruction complex to inhibit YAP nuclear localization 88 (left). AMPK, AMP-activated protein kinase; β -cat: β -catenin; β -TrCP, betatransducin repeat containing protein; FZD, Frizzled; GSK3, glycogen synthase kinase 3; LRP5/6: low-density lipoprotein receptor-related protein 5/6; MAP4K, MAP kinase kinase kinase kinase; MVB, multi-vesicular body; MST, mammalian Ste20-like kinase; NF2, neurofibromatosis type 2; PKCζ , protein kinase C, zeta; SAV1, Salvador 1; SCD1, stearoyl-CoA-desaturase 1; WIP, WASP-interacting protein.
feature of epithelial-mesenchymal transition (EMT), a change in cell morphology associated with changes in cell fate and acquisition of stemness traits. Consistently, YAP/TAZ are activated by EMT and are required downstream to confer cancer stem cell attributes 57, 59 . The Hippo cascade is a prime input for YAP/TAZ activity and the first mechanism discovered for YAP/TAZ regulation. Therefore 'Hippo signalling' is often used as a surrogate term for 'YAP/TAZ activity' . This would seem incorrect, both because the Hippo cascade regulates downstream effectors other than YAP/TAZ (ref. 60 ), and because the Hippo pathway might not be the main player of YAP/ TAZ-modulation in diverse physiological and pathological settings. In fact, there are several LATS-independent cases of YAP/TAZ regulation, including mechanotransduction, RhoGTPase signalling, inflammation and metabolism 12, 13, 21, [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] . Worth noting is that, in mammary gland, lung, heart, kidney, pancreas, epidermis and nervous system-tissues in which tumour emergence is associated with high YAP/TAZ activity-genetic depletion of Hippo pathway components does not result in tumour formation 61, 69, [73] [74] [75] [76] [77] . This highlights how a combination of events, Hippo-dependent and -independent, must accumulate to activate YAP/TAZ above the threshold required for tumorigenesis 7 . Moreover, direct phosphorylation of YAP by LATS may not be sufficient to inhibit YAP nuclear accumulation: YAP phosphorylation on the prime LATS-target residue S127 does not prevent YAP nuclear localization 78 ; inhibition of nuclear export results in nuclear accumulation of phosphorylated YAP (refs 12, 79 ); and mechanical deformation of the nucleus can modulate subcellular localization of YAP in a phosphorylation-independent manner 46 . That said, although cell mechanics can regulate YAP/TAZ in a manner uncoupled from their phosphorylation by LATS1/2, LATS1/2 kinase activity can also be modulated by F-actin levels and contribute to YAP/TAZ mechanotransduction 13, 33, 80, 81 . We thus envision Hippo signalling as one segment of a broader framework of molecular events by which the cell structure acts as overarching determinant of YAP/TAZ function. The reader may refer to other reviews for a more detailed discussion on this topic 9, 81 .
Wnt-YAP/TAZ signalling
Besides their roles as effectors of the Hippo and mechanotransduction pathways, YAP/TAZ are also biochemical and transcriptional mediators of Wnt signalling, providing a mechanistic link to the observed overlap between Wnt and YAP/TAZ biology. At the core of the canonical Wnt pathway, the destruction complex is a multi-protein machinery that controls intracellular levels of β -catenin, but is also a critical checkpoint coordinating both β -catenin and YAP/TAZ activity 7, 81 (Fig. 2b) . Strikingly, in the mouse small intestine, YAP/TAZ are not only massively activated by inactivation of destruction complex components (as in adenomatous polyposis coli (Apc) mutant cells) but are also essential for the pro-tumorigenic effects of aberrant Wnt signalling [82] [83] [84] . Similarly, YAP/TAZ mediate the effects of Wnt signalling to promote proliferation and tumorigenesis of CSCs (refs 62, 82, [85] [86] [87] [88] [89] , to regulate differentiation of mesenchymal stem cells (MSCs, ref. 62 ) and to sustain the intestinal crypt regeneration of organoids in vitro or after tissue damage in vivo 26, 36, 82, 88 . Notably, cytoplasmic YAP/TAZ favour the recruitment of β -transducin repeats-containing protein (β -TRCP) to the destruction complex, and as such facilitate β -catenin degradation 82 ( Fig. 2b) . Therefore, YAP/TAZ nuclear translocation, induced by mechanical signals or Hippo inactivation, can lead to β -catenin nuclear localization 74, 82, 90, 91 . This suggests a coherent regulation of YAP/TAZ and β -catenin that explains why activation of the Hippo pathway, by controlling YAP/TAZ cytosolic localization, also restrains Wnt-β -catenin signalling 81 . Moreover YAP/TAZ can inhibit Wnt signalling by inhibiting Dishevelled (DVL) 92, 93 . β -catenin itself is also regulated by mechanical cues 94 . This mechanism raises the possibility that mechanical regulation of YAP/TAZ and β -catenin may be connected. Indeed, in epithelial monolayers, mechanical strains induce nuclear translocation of YAP followed by that of β -catenin, collectively leading to transcriptional activation required for cycle re-entry 95 . Finally, an additional layer of interconnection between YAP/TAZ and β -catenin occurs on chromatin as detailed in Table 1 .
In addition to the canonical Wnt-β -catenin pathway, activation of the Wnt-FZD/ROR pathway promotes YAP/TAZ signalling required for cell migration and osteogenic differentiation, acting through G protein alpha subunits (Gα ) 12/13-RhoGTPases (ref. 96 ) (Fig. 2b) .
Metabolic control of YAP/TAZ
A number of reports indicate a close connection between glucose homeostasis and YAP/TAZ activity 97 . Glucose availability has recently been found to sustain YAP/TAZ activity by feeding the hexosamine biosynthesis pathway (HBP). Mechanistically, high levels of glucose lead to production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) resulting in increased YAP O-GlcNAcylation, which can stabilize YAP protein levels 98, 99 . Moreover, phosphofructokinase 1 (PFK1), responsible for the most rate-limiting step of the glycolytic cascade, promotes the YAP/TAZ transcriptional program by stabilizing their interaction with TEA domain (TEAD) transcription factors 64 . A metabolic shift from oxidative respiration to aerobic glycolysis, the 'Warburg effect' , is a hallmark of cancer. Under these conditions, glycation of Hsp90 impairs its chaperone activity on LATS1 ultimately contributing to YAP/TAZ activation 100 . On the other hand, shortage of glucose availability inhibits YAP/TAZ activity, mainly through activation of the cellular energy sensor AMP-activated protein kinase (AMPK), which in turn regulates YAP/TAZ activity through multiple parallel phosphorylation events, either directly or through LATS1 (ref. 97 ). Collectively, these studies suggest that the increased glucose consumption supporting cell proliferation in cancer cells also sustains a pro-tumorigenic transcriptional program through YAP/TAZ.
Metabolism of lipids through the mevalonate/cholesterol biosynthetic pathway is linked to the regulation of YAP/TAZ by promoting proliferation and migration of mammalian cells or tissue overgrowth in Drosophila embryos. Mechanistically, mevalonic acid sustains YAP/TAZ activity through the production of geranylgeranyl-pyrophosphate, which is covalently attached to the RhoAGTPase and required for membrane localization and activation of this protein. In turn, membrane active RhoA activates YAP/TAZ in a LATS1/2-independent manner 71, 101 . The mTOR pathway represents a prototypical mechanism for control of cell size and proliferation in response to nutrients, growth factors and cellular energy levels 102 . The mTORC1 kinase complex sustains YAP/TAZ activity, in a model of perivascular epithelioid tumours, by inhibiting the autophagosome-dependent lysosomal degradation of YAP protein in response to nutrient availability 103 . Moreover, the mTORC2 kinase complex can activate YAP/ TAZ through inhibitory phosphorylation of AMOT proteins 104 , or MST1 (ref. 105 ), although the physiological relevance of this activity remains unknown.
YAP/TAZ regulation by gPCr signalling
Several metabolic regulators, hormones and growth factors act as extracellular signals through different classes of G-protein-coupled receptors (GPCRs) that, in turn, are able to induce or repress YAP/ TAZ activity 52, 97 . Specifically, stimulation of Gα -coupled receptors by multiple ligands, including lysophospholipids sphingosine 1-phosphate (S1P), lysophosphatidic acid (LPA), thrombin, oestrogens and acetylcholine, results in YAP/TAZ activation through promotion of a RhoGTPase-regulated F-actin cytoskeleton, in a manner that is either LATS1/2-dependent or independent 52, 66, 80, 97 . Conversely, Gα -coupled GPCR signalling elicited by glucagon or epinephrine represses YAP/TAZ activity through cAMP/PKA-dependent inhibition of RhoA-GTPase (refs 80, 106 ) (Fig. 2a) . Constitutive YAP/TAZ activation by aberrant expression of GPCRs, or by genetic mutations affecting their associated heterotrimeric G-proteins, is implicated in the malignant promotion of uveal melanoma 107 , skin basal-cell carcinoma 108 and in sarcomas associated with Kaposi herpesvirus (KSHV) 109 .
Crosstalk with growth factor and inflammatory signalling
YAP/TAZ are interconnected with signalling pathways initiated by soluble growth factors through reciprocal mechanisms of regulation. As reviewed elsewhere, these include transforming growth factor beta (TGF-β ), bone morphogenetic protein (BMP), Hedgehog (Hh) and epidermal growth factor receptor (EGFR) pathways 52 . Following intestinal injury, during which inflammation contributes to cell proliferation 110 , the release of interleukin (IL)-6 and IL-11 activates YAP/TAZ-dependent proliferation in the intestinal crypt. Mechanistically, interleukin-mediated glycoprotein130 (gp130) signalling induces the activation of Src family kinases (SFKs) that trigger YAP activity by direct tyrosine phosphorylation 72 . Moreover, increased YAP/TAZ activity can upregulate gp130 signalling through a transcriptional mechanism that results in an amplification loop, as observed during tumour growth initiated by APC loss 111 . TAZ also regulates the differentiation of CD4
+ T helper 17 (T H 17) cells (a pro-inflammatory subset) and promotes the expression of T H 17 cell-associated genes, including IL-17A (ref.
112
). This may be relevant for colorectal cancer (CRC), as high levels of IL-17A and T H 17 cells in the tumour microenvironment promote CRC progression 113 .
Controlling YAP/TAZ in the nucleus
Following nuclear translocation, YAP/TAZ elicit their biological functions mainly by regulating gene transcription through their association with the DNA-binding TEAD 1-4 family members [114] [115] [116] . Genome-wide, the mammalian complex of YAP or TAZ with TEAD (YAP/TAZ-TEAD) is directly recruited to promoter regions of a minority of YAP/TAZ targets, as most associations to chromatin occur at distant enhancers that contact their cognate promoters through DNA looping 115 . Enhancer-bound YAP/TAZ-TEAD complexes regulate gene transcription by inducing p300-dependent acetylation at lysine 27 of histone H3 (H3K27ac) 114 , through recruitment of the Mediator complex and induction of transcriptional elongation through the pause release of RNA polymerase II (ref. 116 ) (Fig. 3a) . On DNA, YAP/TAZ-TEAD usually act in combination with other TFs bound at neighbouring cis-regulatory elements. Analysis of ChIP-seq data revealed that the activator protein-1 (AP-1) TFs are recruited on a large set of enhancers bound by YAP/TAZ-TEAD. This allows synergistic cooperation to control tumour proliferation, migration and invasion, to drive epigenetic reprogramming of cancer cells into a stably chemoresistant state and regulate bone metabolism 115, [117] [118] [119] . Other TFs acting in combination with YAP/TAZ on the cis-regulatory elements of individual genes are listed in Table 1 (for example, runt-related transcription factor 2 (RUNX2)) 120, 121 , which also includes work on the potential role of YAP/TAZ as transcriptional repressors.
YAP/TAZ can interact with nuclear proteins that compete with their association with TEAD. Vgl-like-4 (VGLL4) counteracts YAP/ TAZ-dependent tumour growth by disrupting their interaction with TEAD in gastric, lung and breast cancer [122] [123] [124] . Notably, VGLL proteins can also serve as binding partners to TEAD, alternative to YAP/TAZ, promoting anchorage independent growth and cell proliferation. The structural determinants of this association were recently reported in ref. 125 . Another example of a nuclear inhibitor is T-lymphoma invasion and metastasis-inducing protein 1 (TIAM1), which prevents the interaction between TEAD and YAP/TAZ in the nucleus (probably by sequestering YAP/TAZ), thereby inhibiting migration and invasion of CRC cancers 87 .
YAP/TAZ downstream genes and effector pathways
Sustained cell proliferation is probably one of the best-characterized YAP/TAZ-dependent biological responses. Mechanistically, YAP/TAZ stimulate cell proliferation by controlling the expression of genes directly involved in the cell cycle, such as proteins involved in DNA replication and repair, cyclins and their regulators, mitotic kinases and factors required for completion of mitosis 115, [126] [127] [128] . Moreover, YAP/TAZ indirectly control cell proliferation through the induction of transcriptional regulators of the cell cycle 115, 128 ( Fig. 3b) . Intriguingly, Myc-dependent transcription requires the recruitment of YAP to MYC/TEAD-loaded promoters, potentially amplifying the effects of YAP/TAZ on cell proliferation 129 . Thus, MYC-driven transcription is substantially a YAP/TAZ-driven gene expression program. This expands the long-neglected chromatin layer as a pivotal element of the integration of YAP/TAZ with other oncogenic or lineage-specific transcription factors. YAP/TAZ further control the expression of CTGF, CYR61, AXL and anti-apoptotic genes of the Bcl2 and IAP families. These targets may support YAP/TAZ-driven chemoresistance [130] [131] [132] and protection against apoptosis 7, 133 . In some experimental contexts, YAP may display poorly understood tumour suppressive responses. Intriguingly, individual cells retaining elevated YAP levels undergo apoptosis when they are no longer enmeshed into a YAP-supporting microenvironment 134 . Similar tumour suppressive responses exist in colorectal cancer 92 . Exciting evidence in Drosophila suggests that part of the tumour suppressive effects of YAP are connected to 'cell competition' phenomena 135 . Whether cell competition occurs in adult mammalian tissues and, if so, in a YAP/TAZ-regulated manner, remains unknown.
YAP/TAZ also activate a transcriptional program required for cardiomyocyte protection from reactive oxygen species (ROS) generated after cardiac injury and ischemic damage 136, 137 . In these conditions, active YAP fosters cardiomyocyte survival and partial heart regeneration, either by cooperating with TEAD-PITX2 to regulate the expression of a large subset of PITX2 targets 137 , or by using FOXO1 as DNA-binding platform to induce the expression of antioxidant genes 136 
.
As outlined above, several metabolic pathways can regulate YAP/ TAZ. In response, YAP/TAZ activation reprograms cell metabolism to sustain massive cell proliferation. Mechanistically, YAP/TAZ modify metabolism through direct transcriptional regulation of glycolysis enzymes [138] [139] [140] , HBP (ref. 99 ), glutamine metabolism and nucleotide biosynthesis 141, 142 . In addition, YAP/TAZ can induce the breast cancer anti-oestrogen resistance 4 (BCAR4) long non-coding RNA, leading to upregulation of the glycolytic PFKFB3 enzyme 140 , supporting YAP/TAZ transcriptional responses 64 . Furthermore, YAP/TAZ upregulation through EphA2-RhoA-ROCK signalling is connected to raised glutamine metabolism 142 . YAP/TAZ activate mTOR signalling by promoting the transcription of several regulators of the mTOR pathway, such as the mTORC1 activator Ras homologue enriched-in-brain (RHEB), required for proliferation of transient-amplifying (TA) cells during tissue renewal of mouse incisors 68 ; the L-type amino acid transporter 1 (LAT1), which enhances amino acid uptake and consequent mTORC1 activation 143 ; and the microRNA miR29, which inhibits PTEN translation and PI3K-mediated activation of mTORC1 and mTORC2 kinases 144 . However, large gaps remain in our understanding of the potential overlap between Hippo, mTOR and YAP/TAZ in the control of cell and organ size.
YAP/TAZ impact on Notch
Work in various cellular contexts has revealed the importance of functional and molecular connections between YAP/TAZ and Notch signalling ; e, activated myofibroblasts during liver fibrosis 17 ; f, lung branching morphogenesis 154 ; g, endothelial cells during vascular development 155, 156 ; h-i, activated CAFs and breast cancer cells 22, 157 . AP-1, activator protein 1; FA, focal adhesions; MCM, mini chromosome maintenance; Pol-II, RNA polymerase II; Polα , DNA polymerase alpha; Polε , DNA polymerase epsilon; TSS, transcription start site.
activation of YAP/TAZ that upregulate DLL1, JAG2 and DLL3 ligands, resulting in cell-autonomous cis-inhibition of Notch signaling 149 . Thus the structural features of the microenvironment are translated into dynamic changes of YAP/TAZ activity to orchestrate spatial control of self-renewal versus differentiation of stem cells.
Another exciting discovery is that YAP mechanotransduction, feeding on Notch signalling, is at the center of the enigmatic somitic 'segmentation clock' (periodic waves of gene function that travel through the presomitic mesoderm) 150 .
It appears that what regulates this oscillatory system are the extensive biomechanical changes occurring in cells exiting gastrulation (including collective movement and compaction) patterning YAP activity and leading to repression of Notch (ref. 151 ).
The influence of YAP/TAZ on cell mechanics
In light of the overarching role of cell mechanics in controlling YAP/TAZ activity, it should be mentioned that an important subset of the YAP/TAZ transcriptional program is devoted to the installment of a positive feedback loop that promotes F-actin remodelling and high mechanical signalling that further supports YAP/TAZ activity. Such a feedback mechanism is illustrated by the medaka fish hirame mutant, in which a loss-of function mutation of YAP causes flattening of the entire fish body, due to impaired development of actomyosin-mediated tissue tension 152 . Further, ChIP-seq analysis on MSCs cultured on substrates of different rigidities has revealed that mechanically activated YAP/TAZ can enhance the assembly of FA complexes by directly promoting the transcription of integrins and FA docking proteins 153 (Fig. 3c) . During cardiomyocyte regeneration, YAP/TAZ directly promote expression of F-actin regulatory proteins and adhesion molecules, including components of the DGC (ref. 38 ) (Fig. 3d) . During liver fibrosis, YAP/TAZ promote the sustained expression of integrin-β 1 by activated myofibroblasts 17 ( Fig. 3e) . Conditional YAP knockout in mice impairs branching morphogenesis of the lung, where a number of YAP/TAZ targets modulate actomyosin contractility 154 (Fig. 3f) . YAP/TAZ also crosstalk with vascular endothelial growth factor (VEGF) during angiogenesis. During vascular development, cytoskeletal rearrangement of The biological model in which the ChIP experiments were performed is indicated in brackets, when available. ND, not determined; hESC, human embryonic stem cell; PDAC, pancreatic ductal adenocarcinoma; SSC, skeletal stem cells; ZEB1, zinc finger E-box-binding homeobox 1; ICD-ERBB4, Erb-b2 receptor tyrosine kinase 4 intracellular domain; E2F, E2 factor ; NuRD, nucleosome remodelling deacetylase; SMADs, small mother against decapentaplegic; NICD/RBPJ, notch intracellular cleaved domain/recombination signal-binding protein 1 for immunoglobulin kappa J region; TCF, T-cell factor; TBX5, T-box 5.
endothelial cells induced by VEGF triggers activation of YAP/ TAZ, which feeds back on cytoskeletal gene expression to sustain endothelial remodelling and ensure correct VEGF receptor trafficking 155, 156 (Fig. 3g) . Another 'inside-out' positive feedback loop is found in breastcancer-associated fibroblasts (CAFs), in which YAP/TAZ directly promote the expression of modulators of F-actin contractility. Increased contractility fosters the deposition of fibrous collagen that, by enhancing ECM stiffness, sustains YAP/TAZ activity in both CAFs and epithelial cancer cells 22 (Fig. 3h) . In breast cancer cells, expression of TAZ can induce cancer stem cell properties 57 but also sustain its own activity by inducing transcription of laminin 511, a pro-YAP/TAZ ECM component 157 (Fig. 3i) . In cancer cell lines, YAP/TAZ-TEAD and AP-1 cooperate to activate Dock proteins, a family of small GTPases that regulate Rac1 and Cdc42 to drive cytoskeletal organization, cell adhesion and motility 117 .
Future outlook
Interest in YAP/TAZ biology and regulation was initially inspired by pioneering work on the Hippo cascade and its roles in controlling organ size and tumorigenesis. Subsequently, we learned that the Hippo kinase cassette is a segment of a broader framework in which YAP/TAZ are regulated by the structural features of cells and tissues in a Hippo-dependent and -independent manner. New data have shed light on the molecular mechanisms by which YAP/TAZ act as sensors and effectors of the cell's behaviour in a tissue context.
A model is emerging in which cytoskeletal organization, reflecting tissue-level mechanical forces, serves as an overarching determinant of YAP/TAZ activation. In turn, through feedback and crosstalk mechanisms, YAP/TAZ impact a variety of cellular events, from growth factor responsiveness to metabolism. Here, we have attempted to integrate data from different model systems to offer a comprehensive picture, but it should be noted that the relevance of each step might be different in distinct cells and in vivo conditions. YAP/TAZ activation can endow cell plasticity, reprogramming primary, genetically normal differentiated cells into their corresponding tissue-specific stem or progenitor cells 158 . There are obvious implications for regenerative medicine, but many questions remain. What are the constituents of this program? What are the partner transcription factors by which YAP/ TAZ operate in various histotypes? Are these tissue-specific or universal? What are the downstream genes? Can we use YAP/TAZ to epigenetically explore the so-far enigmatic self-renewal properties of stem cells? Furthermore, the mechanisms by which YAP/TAZ are regulated by cell mechanics remain poorly understood. YAP/TAZ mechanotransduction can be independent from LATS, yet LATS itself can be regulated by F-actin, potentially reinforcing the mechanotransduction pathway. Moreover, the Hippo pathway feeds back on cytoskeletal organization by directly phosphorylating cytoskeletal components 43, 159 . However, it is unclear how this interplay is orchestrated.
The Hippo pathway has additional targets other than YAP/ TAZ, including regulation of chromosome segregation, the spindle checkpoint, p53, hormonal receptors and immune cell function 60, 160 . Ironically, it is still unclear whether YAP/TAZ are instrumental or dispensable for the organ size control that made the Hippo pathway famous.
Finally, YAP/TAZ activation is instrumental for both cancer and regeneration. The essential role of YAP/TAZ in the emergence of solid tumours resembles the 'transcriptional addiction' phenomenon observed in cancer cells, describing the disproportional use of enhancer elements 7, 161 It is currently unclear whether the knowledge outlined in this Review can be used to combat excess YAP/TAZ activity in cancer. Addressing these issues might have immediate clinical implications for an anti-YAP/TAZ-based cancer therapy.
